Since 2017, the use of medicinal cannabis has taken an increasingly important position in pain and palliative medical care. As an alternative therapy or in concomitant medication, medical cannabis can be prescribed by a physician for serious diseases.
The full spectrum cannabis extract Naxiva® PanaxolTM ONKO enables complementary therapy with the combination of active ingredients THC and CBD in the unique ratio of 5:1. By taking the individual dosage orally, the patient helps to determine the therapy and independently takes care of his symptom control.
AxioNovo has incorporated the product Naxiva® PanaxolTM ONKO to its portfolio precisely for this purpose and would like to support physicians and patients with individual therapy in the field of oncology.
Further information and free service documents of Naxiva® PanaxolTM ONKO can be found in our download area on the right.